MIL-OSI United Kingdom: expert reaction to EMA decision on lecanemab for Alzheimer's disease

Press/Media: Research

Period26 Jul 2024

Media contributions

1

Media contributions

  • TitleMIL-OSI United Kingdom: expert reaction to EMA decision on lecanemab for Alzheimer's disease
    Media name/outletForeignAffairs.co.nz
    Media typeWeb
    Country/TerritoryNew Zealand
    Date26/07/24
    PersonsTara Spires-Jones
View all 1
View less